The New York Times

F.D.A. Approves New Weight-Loss Pill

The drug, made by Eli Lilly, could offer a more convenient option for patients who want to avoid injections. By Dani Blum and Rebecca Robbins The Food and Drug Administration on Wednesday approved a ...

Why Daniel Kinahan’s arrest WON’T spark end for drug clan’s £830m empire despite cops warning ‘we’re not done yet’

LIVING a gilded life of luxury among Dubai’s elite, alleged drug kingpin Daniel Kinahan arrogantly believed he was safe from ...

These 13 Celebrity Couples Waited Years — or Decades! — to Get Married

In Hollywood, not every love story is quick — some celebrity couples take the long road to “I do.” While many couples have ...

GOP, Dem challenger hit Rebecca Cooke for outside political work

Rebecca Cooke cultivates an image as a political outsider, but her opponents say that masks her years of outside work for ...

Celebrities You Didn't Know Were Related (Including 2 Actresses Who Are Distant Cousins with a British Royal)

Snoop Dogg, Gabrielle Union, Lance Bass, Jason Sudeikis and more stars have high-profile (and super surprising) connections ...
FiercePharma

Eli Lilly takes the court with 150th anniversary campaign to catch Final Four crowd

Eli Lilly has published a video about how medicines affect lives to mark its 150th anniversary and the arrival of college basketball stars in its home city. Indianapolis-based Lilly will celebrate 150 ...
CNBC

Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

Eli Lilly will pay up to $7.8 billion to acquire Centessa Pharmaceuticals. Centessa is developing orexin agonists to treat narcolepsy and excessive drowsiness. The deal is the latest from Lilly, which ...
CNBC

Lilly seals up to $7.8 billion deal for Centessa in sleep disorder bet

Eli Lilly said on Tuesday it would buy Centessa ⁠Pharmaceuticals ‌in ⁠a deal valued at up to $7.8 billion as the U.S. drugmaker looks to diversify beyond its metabolic portfolio and expand into ...
STAT

AI drug developer Insilico Medicine and Lilly ink commercialization deal worth up to $2.75 billion

Alex Zhavoronkov, CEO of Insilico Medicine, can’t stop complimenting Eli Lilly. “Lilly is better in AI than Insilico, and no other company is better in AI than us … except for these guys,” he said. He ...
Forbes

FDA Approves Eli Lilly’s Weight Loss Pill—Second Weight GLP-1 Drug In Pill Form

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The Food and Drug Administration has approved Foundayo, Eli Lilly’s new GLP-1 pill to treat ...
Reuters

Lilly's weight-loss pill wins US approval, sets up next battle with rival Novo Nordisk

Lilly pill led to 12%-15% reduction in body weight in clinical trials Will be sold as Foundayo and available beginning April 6 FDA fast-tracked approval under Trump-era voucher program The Lilly drug, ...
FiercePharma

Lilly presses for UK deal that would see higher drug prices in exchange for resumed investments: FT

After high-profile moves by Eli Lilly and other Big Pharmas to pause their U.K. investments last year, the Indianapolis-based pharma giant is making its desires known—and sharing an update on its ...